YOLFTbeta
30

Shanghai Menon Animal Nutrition Technology Co. Ltd.

301156 · SHE · Consumer Defensive / Packaged Foods

10.28CNY-0.22 (-2.10%)

Price History

Full chart

Market Stats

Previous Close10.50
Open10.45
Day Range10.26 – 10.58
52-Week Range9.75 – 16.35
Volume2.49M
Market Cap2.17B
P/E (TTM)43.56
Forward P/E0.00
EPS0.27
Dividend Yield4.45%
Beta0.50
50-Day Avg11.57
200-Day Avg13.46

About

Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research and development, production, and sale of feed additives and enzymatic protein feed raw materials in China and internationally. The company offers swine products, such as feed flavoring and feed sweeteners; combination enzymatic protein digestion; feed acidifier; and antibacterial organic acid preparations, sodium butyrate, new generation of butyric acid preparations and supramolecular protective essential oils, embedded multilayer coated zinc oxide, and cottonseed enzymatic hydrolysate. It also provides ruminant products, including highly concentrated slow-release nitrogen source; rumen-protected choline chloride, rumen-protected niacin, and coated ammonium chloride; rumen-passed glucose; and rumen-protected methionine and rumen-protected lysine. In addition, the company offers microcapsule acidifier, liquid acidifier, plant essential oils and organic acids, organic acids and plant essential oils, solid plant essential oils, and emulsifier. Its products are used for pigs, ruminants, poultry, aquatic animals, and pets. Shanghai Menon Animal Nutrition Technology Co., Ltd. was founded in 1997 and is based in Shanghai, China.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Wei Hong
  • Employees461
  • HeadquartersNo. 151 Lihong Road, Shanghai, China, 201807, China
  • Websitehttps://www.sinomenon.com

Leadership

  • Mr. Wei HongChairman of the Board & GM · b. 1968
  • Ms. Qian ZhouFinancial Director & Accounting Supervisor · b. 1978
  • Mr. Ying XiongDirector & Deputy GM · b. 1970
  • Ms. Ji Hong WangDirector & Deputy GM · b. 1969
  • Ms. Weiwei ZhangDeputy GM & Board Secretary · b. 1981

Financials

Income Statement

Currency: CNY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue265.82M279.95M420.56M546.25M483.32M504.42M489.93M561.27M
Growth (%)-+5.32%+50.23%+29.89%-11.52%+4.37%-2.87%+14.56%
Cost of Revenue173.42M172.95M269.08M385.77M344.25M354.56M350.27M389.28M
Gross Profit92.40M106.99M151.48M160.49M139.07M149.86M139.66M171.99M
Gross Margin34.76%38.22%36.02%29.38%28.77%29.71%28.51%30.64%
Operating Expense64.20M68.10M74.50M81.29M80.54M83.16M85.14M110.03M
Operating Income28.21M38.89M76.98M79.20M58.53M66.71M54.52M61.96M
Operating Margin10.61%13.89%18.30%14.50%12.11%13.22%11.13%11.04%
EBITDA37.07M48.53M85.54M89.57M68.94M89.51M79.11M87.77M
EBITDA Margin13.95%17.33%20.34%16.40%14.26%17.74%16.15%15.64%
Net Income25.65M34.37M66.71M70.56M52.49M63.05M49.58M54.81M
Net Income Margin9.65%12.28%15.86%12.92%10.86%12.50%10.12%9.77%
R&D18.07M15.09M19.48M22.53M21.38M21.97M20.88M24.84M
R&D as % of Total Revenue6.80%5.39%4.63%4.13%4.42%4.35%4.26%4.43%
Interest Expense651.63K860.25K567.07K1.33M893.54K29.33K189.83K6.95K
Interest Expense % of Total Revenue0.25%0.31%0.13%0.24%0.18%0.01%0.04%0.00%

Balance Sheet

Currency: CNY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets236.24M258.43M346.69M529.69M887.05M838.82M790.27M829.04M
Total Liabilities40.60M41.56M93.03M205.54M105.39M39.72M45.42M98.80M
Total Equity195.64M216.87M253.65M324.15M781.66M799.11M744.85M730.24M
Cash21.28M38.82M66.56M120.90M413.86M359.85M260.25M186.45M
Total Debt10.00M10.50M11.02M111.07M3.99M227.07K154.63K-
Net Debt-11.28M-28.32M-55.55M-9.84M-409.86M-359.63M-260.09M-

Cash Flow

Currency: CNY2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.71M50.60M51.16M90.04M42.05M60.04M67.17M66.49M
Investing Cash Flow-40.72M-19.00M8.73M-128.43M-48.08M-64.02M-64.31M-
Financing Cash Flow-23.41M-15.24M-29.90M91.07M295.09M-48.29M-104.79M-
Capital Expenditure11.10M8.20M34.03M125.80M49.68M38.47M55.94M117.85M
Free Cash Flow6.61M42.40M17.13M-35.76M-7.63M21.56M11.22M-51.36M
Dividends Paid18.65M15.54M30.40M2.17M3.08M48.02M60.86M45.05M
FCF to OCF37.31%83.80%33.48%-39.71%-18.14%35.92%16.71%-77.25%
Dividend Paid to FCF282.29%36.64%177.50%-6.07%-40.34%222.69%542.25%-87.71%

Earnings

Report DateJun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------
EPS Actual0.050.070.080.050.060.130.070.050.060.060.100.050.080.100.080.070.03
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap2.17B
Enterprise Value2.05B
Trailing P/E43.56
Forward P/E0.00
Price / Sales3.32
Price / Book3.00
EPS0.27
Book Value3.98
Revenue (TTM)652.67M
Gross Profit (TTM)186.90M
EBITDA83.37M
Profit Margin7.56%
Operating Margin0.20%
Return on Equity6.88%
Return on Assets4.31%
Shares Outstanding184.11M
Shares Float59.44M
Beta0.50
Dividend Yield4.45%
Dividend Rate0.52
Payout Ratio102.83%

Dividends

20262×
0.20May 29, 20260.08Jan 7, 2026
20251×
0.25Jun 11, 2025
20241×
0.33May 13, 2024
20231×
0.36Jul 3, 2023

Stock Splits

  • May 29, 20261.3:1
  • May 13, 20241.3:1
  • Jul 3, 20231.4:1